Vapi Care Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 8.08 M
as on 16-11-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.92 Cr
as on 16-11-2024
- Satisfied Charges ₹ 118.85 Cr
as on 16-11-2024
- Revenue 7.66%
(FY 2023)
- Profit -69.56%
(FY 2023)
- Ebitda -42.82%
(FY 2023)
- Net Worth -12.98%
(FY 2023)
- Total Assets -3.59%
(FY 2023)
About Vapi Care Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 8.08 M.
The company currently has active open charges totaling ₹28.92 Cr. The company has closed loans amounting to ₹118.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hitesh Shah and Kamal Shah serve as directors at the Company.
- CIN/LLPIN
U24231GJ1996PTC029124
- Company No.
029124
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vapi Care Pharma Private Limited offer?
Vapi Care Pharma Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Vapi Care Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Shah  | Managing Director | 22-Mar-1996 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hitesh Shah | Director | 04-Oct-2018 | Current |
Financial Performance of Vapi Care Pharma.
Vapi Care Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.66% increase. The company also saw a substantial fall in profitability, with a 69.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vapi Care Pharma?
In 2023, Vapi Care Pharma had a promoter holding of 83.85% and a public holding of 16.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2023 | ₹2.00 M | Open |
Others Creation Date: 07 Mar 2023 | ₹2.98 M | Open |
Others Creation Date: 30 Jan 2023 | ₹1.59 M | Open |
How Many Employees Work at Vapi Care Pharma?
Vapi Care Pharma has a workforce of 100 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vapi Care Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vapi Care Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
